Loading...
Home2020-01-16T14:12:51-05:00

GET OUR LATEST REPORTS DELIVERED TO YOUR INBOX

Utopiacap.com launched to the public in July 2019, initially with eight “Hindsight” reports, which looked at suspect tickers after their price declined.  

From August 2019 we started focusing on carefully timed short reports which seek to act as short calls as well as warn potential investors/traders of suspicious tickers. From November 19, 2019, our short reports started being 3rd party verified by  www.breakoutpoint.com

In total, we have covered and published thirteen short reports/calls (twelve profitable), ten of which have been tracked by Breakout Point (nine profitable). Giving us a 90% 3rd party verified success rate.

For more about us click HERE or read latest reports below.

.

Anavex Life Sciences Corp. OTCQB: AVXL Short Report, 9:40am February 19, 2020

Intro: Like all other tickers featured in our short reports, AVXL’s has exhibited unusual behaviour recently, with its price per share more than doubling over the last three weeks. Furthermore, daily trading volume has been considerably above the 6-month daily average and RSI (14) has breached 85. Anavex has gotten itself into a fair number of headlines over recent years, so it didn’t take much digging around to find enough material for [...]

February 19th, 2020|

Agile Therapeutics, Inc. Nasdaq: AGRX Short Report, 9:30am February 18, 2020

Intro: Since early November 2019, Agile Therapeutics, Inc’s share price has seen a four-fold increase and daily trading volume has picked up significantly. We believe this to be rather suspicious, especially when considering other red flags, such as: serious dilution issues over the last year or so, a loan agreement with a “spiral of death” creditor, a loan facility with a well-known yet dubious institutional shareholder , and a CEO that has [...]

February 18th, 2020|

Biotricity, Inc. OTCQB: BTCY Short Report, 9:30am February 13, 2020

Intro: Like all other tickers featured in our short reports, BTCY’s price action has exhibited unusual behaviour recently. Over the last two months it has increased by nearly six-fold. Furthermore, its trading volume has been considerably above the 6-month daily average and RSI (14) has breached 80 on more than one occasion. It didn’t take much digging around to unearth a couple of other red flags, namely: recurrent paid promotion, dilution issues, [...]

February 13th, 2020|

CytoDyn, Inc. OTCQB: CYDY Short Report, February 6, 2020

Intro: Over the last seven weeks CYDY’s share price has a seen a near five-fold increase, daily trading volume has increased drastically and daily RSI (14) breached 80 several times. We looked into it a found some red flags that we would like to share with our readers. Flags include: obscene levels of dilution, poor financials, an underwriter with a horrific FINRA brokercheck record, a “spiral of death” creditor and highly questionable [...]

February 6th, 2020|

MYO Trade Alert. Myomo Inc. 10:25 am February 5, 2020

MYO Chart by TradingView Trade Alert Security Details: Symbol: MYO Outstanding shares: 573,560 Market Cap: $16.8 million Share price at time of publishing: $29.22 February 5, 2020 10:25 am (closing price of last 5 minute candle) [see bottom of page for third party verified blockchain time stamp*] Target price: $17 *timing is of great importance when short selling. This is why all of our trade alerts are time stamped. These time [...]

February 5th, 2020|

Co-Diagnostics, Inc. Nasdaq: CODX Short Report, January 28, 2020

Intro: Over the last three days CODX’s share price has a seen a near three-fold increase, daily trading volume has exceeded 50 million (over three times the number of outstanding shares) and daily RSI (14) has breached 90. This has been on the back of Coronavirus news pieces suggesting that CODX is preparing a test to diagnose the disease. This has also coincided with an offering pricing announcement. We looked into it [...]

January 28th, 2020|

Watchlist Report NVAX, Novavax, Inc., January 21, 2020

Welcome to our first Watchlist Report, in these reports we discuss potential shorts which have not yet met the necessary conditions to be actionable. THESE REPORTS ARE NOT SHORT REPORTS. In the case of NVAX, we would not consider it a short candidate unless its price per share surpasses the $10 mark. Intro: In our first watchlist report we have Novavax (NVAX), whose remarkable price increase and record volume during today’s [...]

January 21st, 2020|

Cemtrex, Inc. Nasdaq: CETX Short report, January 16, 2020

Intro: A quick look at CETX’s price action over the last twelve months will reveal a “bumpy” downward slope. We believe the present time is yet another “bump” in this ticker’s continued yet prolonged southward trajectory. In this short report we will be analysing some of the red flags investors and traders ought to be aware of, such as: securities class action lawsuits, worsening financials, dilution and a couple of institutional shareholders [...]

January 16th, 2020|

CounterPath Corp. Nasdaq: CPAH Short Report, January 13, 2020

Intro: Another week, another short report highlighting red flags to potential investors/traders. This time around we present to you CounterPath Corp. (CPAH). CPAH popped up in our radars last Friday due to its ludicrous 300% price increase relative to Thursday’s closing price, volume exceeding 42 million shares (seven times the number of outstanding shares) and RSI (14) breaching 94. The reason touted for the drastic increase in the company’s share price was [...]

January 13th, 2020|

Trillium Therapeutics Inc. Nasdaq: TRIL Short Report, January 10, 2020

Intro: Once again, we bring to your attention a ticker that has exhibited the usual behaviour that makes us warry. TRIL’s share price saw a near 100% increase yesterday with RSI (14) exceeding 85 and volume reaching record levels by a significant margin. We will thus be taking a look at some of the red flags the company rises in order to offer a more bearish perspective. Security Details (January [...]

January 10th, 2020|

Inpixon Nasdaq: INPX Short Report, January 6, 2020

Intro: INPX short report Another week, another report on a suspicious ticker. This time we present to you Inpixon (INPX). Its share price has increased by more than ten-fold over the last three weeks, volume at all-time record levels by a significant margin and daily RSI (14) exceeds 90. INPX also raises some eyebrows when a look is taken at its share issuance practices, its lenders and the underwriter of one its latest public offerings. [...]

January 6th, 2020|

FuelCell Energy, Inc. Nasdaq: FCEL Short Report, January 2, 2020

Intro: Like most of the tickers featured in our short reports FCEL has exhibited a combination of a drastic price increase (a near ten-fold price increase over the last 2 months), trading volume substantially above the 30-day daily average (151.5 million vs 25.7 million) and high RSI (92). One might argue that this is not a particularly strange occurrence in the world of small caps but upon further inspection we have found [...]

January 2nd, 2020|

Investor Warning: Oncolytics Biotech Inc. Nasdaq: ONCY, December 31,2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Current price: ~$5 Outstanding shares: 20,298,482 Market cap: ~$ 100 million Company information: Oncolytics Biotech Inc. was formed on April 1998 in Alberta Canada. Since its inception it has [...]

December 31st, 2019|

Isracann Biosciences Inc. Pink: ISCNF Short Report, December 27, 2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Intro: Isracann Biosciences Inc. has had quite the run over the last ten trading days with its share price increasing by nearly 100% from less than [...]

December 27th, 2019|

IVERIC Bio Inc. Nasdaq: ISEE Short Report, December 11, 2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Intro: IVERIC Bio, Inc. has had quite the run over the last six weeks with its share increasing from less than $1 to more than $5, [...]

December 11th, 2019|
%d bloggers like this: